Company: HCTI
Filing Date: 2025-03-05
Form Type: PRE 14C
Source: 0001213900-25-020571
Chunk: 14

Company: Healthcare Triangle, Inc.
Filing Date: 2025-03-05
Form: PRE 14C
Chunk 14
---
 effective time of the Authorized Share Increase,
if the proposed Authorized Share Increase is implemented at the direction of the Board, will be the date and time that the certificate
of amendment affecting the Authorized Share Increase is filed with the Secretary of State of the State of Delaware or such later time
as is specified therein. The exact timing of the Authorized Share Increase will be determined by our Board based on its evaluation as
to when such action will be the most advantageous to us and our stockholders, and the effective date will be publicly announced by us.
The Authorized Share Increase may be delayed or abandoned without further action by the stockholders at any time prior to the effectiveness
of the Certificate of Amendment filed with the Secretary of State of the State of Delaware, notwithstanding the Majority Shareholder’s
approval of the Authorized Share Increase, if the Board, in its sole discretion, determines that it is in the best interests of the Company
and its stockholders to delay or abandon the Authorized Share Increase.

<div align='center'>8

ISSUANCE APPROVAL</div>

On February 28, 2025, the Company consummated
a private placement (the “Private Placement”) pursuant to a securities purchase agreement (“Purchase Agreement”)
with institutional investors (the “Purchasers”) for the purchase and sale of approximately $15.2 million of units
(each, a “Unit”), each Unit consisting of one share of Common Stock or one pre-funded warrant (a “Pre-Funded Warrant”) to purchase one share of Common Stock, a Series A common stock purchase warrant to purchase one share of common Stock
(a “Series A Warrant”) and a Setries B common stock purchase warrant to purchase one share of Common Stock (a “Series B Warrant” and together with the Series A Warrant, “Purchase Warrants”), at a price of $0.42 per Unit (or
$0.41999 per Unit, in the case of Units containing Pre-Funded Warrants). The entire transaction was priced at the market under Nasdaq
rules..

The initial exercise
price of each Purchase Warrant is $0.84 per share of Common Stock. The Purchase Warrants terminate on the fifth anniversary of the later
of (x) effective date of stockholder approval and (y) the earlier of (i) the effective date of the registration statement (the “Registration Statement”) filed by the Company to register the Registerable Securities or (ii) the date that the Registerable Securities
can be sold, assigned or